MedTrace Logo

Therapeutic Effects of Traditional Chinese Medicine, Shen-Mai San in Cancer Patient Undergoing Chemotherapy or Radiotherapy

NCT01580358 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-06-21

No results posted yet for this study

Summary

Using Shen-Mai-San for cancer patients undergoing chemotherapy or radiotherapy could help these people improve the quality of life.

Conditions

  • Cancer Patients Undergoing Chemotherapy or Radiotherapy

Interventions

DRUG

Shen-Mai San

Shen mai san is composed of three herb medicines, Ginseng radis, Liriope spicata, and Schizandrae fructus and was manufactured into concentrated herbal extract and packed with 0.5g per capsule and labeled by Sun-Ten pharmaceutical company in Taiwan with good manufacturing practice (GMP).

DRUG

Starch

It was packed in granules with 0.5gm starch. Patients took eight granules three times per day for four weeks.

Sponsors & Collaborators

  • Committee on Chinese Medicine and Pharmacy

    collaborator OTHER_GOV

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • Lun Chien Lo, MD. PhD · Changhua Christian Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-06-30
Completion
2012-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01580358 on ClinicalTrials.gov